Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05145543
Other study ID # 17300428
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date December 1, 2021
Est. completion date March 2022

Study information

Verified date November 2021
Source Assiut University
Contact Ghada Abo Elfadl, MD
Phone 01005802086
Email ghadafadl77@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic sinusitis (CRS) is a high incidence disease characterized by pus, nasal obstruction, olfactory disturbance, headache, and other symptoms, lasting for more than 12 weeks, with severe cases having ocular compression and visual impairment, which can cause cranial, eye, and lung complications. Chronic sinusitis is a high-risk disease.


Description:

One of the main concerns about using packing is that the removal is usually very painful and can be very bothersome. This procedure may even result in syncope by the activation of the vasovagal reflex system. There have been a few studies suggesting that nasal packs should not be used because removal from the nose causes serious discomfort and is painful. Many patients who have undergone nasal surgery report that the removal of the pack was the most painful part of the experience. Postoperative pain is an acute inflammatory pain that starts with surgical trauma and ends with tissue healing. It can be harmful to organ systems by initiating inflamma¬tion through different mechanisms, and the alleviation of postoperative pain is considered important for obtaining homeostasis. Pain may initiate atelectasis due to improper coughing, immobilization may cause thromboembolism and catecholamine discharge may induce cardiovascular side effects and undesired changes in neuroendocrine or meta¬bolic function


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date March 2022
Est. primary completion date March 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - • ASA physical status I-II patients - scheduled for elective FESS surgery. • Age from 18 to 65 years patients Exclusion Criteria: - • Age>18 and<65 years patients, - Previous history of FESS, - Patients with sensitivity to anesthetic agents in the study, - Patients who will do additional septoplasty or turbinate surgery, - Patients with disturbance of blood coagulation, including pro¬thrombin time (PT)/partial thromboplastin time (PTT) prolon¬gation, purpura, and spontaneous bleeding;

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Saline 0.9%
0.9 NaCl % (Saline) (5 ml) will be applied
Levobupivacaine Hydrochloride
0.25 % levobupivacaine (5 ml) will be applied.
Fentanyl
fentanyl plus 0.25 % levobupivacaine (5 ml) will be applied.
Dexamethasone
Dexamethasone plus levobupivacaine (5 ml) will be applied.

Locations

Country Name City State
Egypt Assiut governorate Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Chaaban MR, Rana N, Baillargeon J, Baillargeon G, Resto V, Kuo YF. Outcomes and Complications of Balloon and Conventional Functional Endoscopic Sinus Surgery. Am J Rhinol Allergy. 2018 Sep;32(5):388-396. doi: 10.1177/1945892418782248. Epub 2018 Jun 27. — View Citation

Krings JG, Kallogjeri D, Wineland A, Nepple KG, Piccirillo JF, Getz AE. Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2014 Apr;124(4):838-45. doi: 10.1002/lary.24401. Epub 2013 Oct 9. — View Citation

Stankiewicz JA, Lal D, Connor M, Welch K. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope. 2011 Dec;121(12):2684-701. doi: 10.1002/lary.21446. Epub 2011 Nov 15. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary time to first post-operative analgesic request when patient require analgesia 24 hours postoperative
See also
  Status Clinical Trial Phase
Completed NCT02840006 - Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass Phase 4
Recruiting NCT06210061 - Propofol-Fentanyl-Dexmedetomidine and Propofol-Fentanyl-Sevoflurane Anesthesia for Major Spine Surgery Under Somato Sensory- and Motor- Evoked Potential Monitoring N/A
Completed NCT06052111 - Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy N/A
Recruiting NCT05243940 - Opioid-free Anesthesia in Thyroidectomies N/A
Recruiting NCT03869346 - Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients
Completed NCT03607110 - Comparison of Efficacy of Anesthesia Administered by Endoscopist or Anesthesiologist on Colonoscopy
Recruiting NCT06386783 - Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects Phase 3
Completed NCT04397406 - Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor Phase 4
Not yet recruiting NCT05985850 - Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy Phase 2
Withdrawn NCT02985177 - A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture Phase 4
Completed NCT03901716 - Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation Phase 4
Recruiting NCT06051227 - Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial Phase 3
Completed NCT04597320 - Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients Phase 4
Active, not recruiting NCT03198208 - Intraoperative Fentanyl Dose on Respiratory Complications N/A
Recruiting NCT05805241 - Pharmacogenetics Analysis of Fentanyl Administered in Newborns
Completed NCT02031016 - Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain Phase 4
Withdrawn NCT01488149 - Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study
Terminated NCT03948464 - Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder Phase 3
Completed NCT04971759 - Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery Phase 2/Phase 3
Recruiting NCT05367336 - Platelet Reactivity With Fentanyl, Morphine, or no Narcotic Early Phase 1